Funded Grants

The V Foundation’s grant making model ensures the most promising cancer research projects at state-of-the-art facilities around the country are funded. Cancer research grants are awarded to innovative researchers with the most cutting-edge ideas on how to improve cancer diagnosis methods, prevent cancer recurrences or defeat cancer. 100% of direct donations are used to fund projects we identify as the most likely to help those diagnosed with cancer.

2024
Oriana Damas, MD, MSCTI
Leveraging Microbiome and Metabolomic Strategies to Target DUOX2 Activity for Colorectal Cancer...
Read More
2024
Caroline Bartman, PhD
Targeting vitamin B1 metabolism to starve colorectal cancer
Read More
2024
Melissa Reeves, PhD
Spatial regulation of suppressive macrophages by Cx3cl1 and consequences for anti-tumor immunity
Read More
2024
Christine Eyler, MD, PhD
Deciphering Epigenetic Drivers of Concerted Cell Fate Changes in Rectal Cancer Radiation...
Read More
2024
Alejandro Villarino, PhD
Comprehensive molecular and therapeutic assessment of STAT3-driven T cell malignancies
Read More
2024
Andrea Cercek, MD
Neoadjuvant Botensilimab and Balstilimab in mismatch-repair proficient rectal adenocarcinoma
Read More
2024
Josephine Taverna, M.D.
AXL-STAT3-PD1 targeting of tumor immune microenvironments
Read More
2024
Carla Nowosad, PhD
Tracking and targeting germinal centers in colorectal cancer
Read More
2024
Jessica Stark, PhD
Unlocking the potential of glycans for colorectal cancer immunotherapy
Read More
2024
Esther Rheinbay, PhD
Defining the consequences of sex chromosome loss in uveal melanoma
Read More
2024
Peter Hosein, MD
Overcoming platinum resistance in homologous repair deficient pancreatic cancer with combination immunotherapy
Read More
2024
Humsa Venkatesh, PhD
Normalizing Dysregulated Neural Circuit Activity for Adult Glioma Treatment
Read More
2024
Jay Spiegel, MD, FRCPC
Multi-modality multi-targeted immunotherapy for treatment of aggressive large B-cell lymphomas
Read More
2024
Ian Pollack, MD
Metabolic strategies to improve outcome for DIPGs
Read More
2024
Hemn Mohammadpour, DVM, PhD
Phase I trial of SX-682 a CXCR 1/2 inhibitor in combination with...
Read More
2024
Daniel Wahl, MD, PhD
Measuring and targeting amino acid metabolism in brain cancer
Read More